Testing effectiveness (Phase 2)Study completedNCT00633789
What this trial is testing
Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types
Who this might be right for
Advanced Non-small Cell Lung CancerTransitional Cell CarcinomaSoft Tissue Sarcoma+2 more
Bristol-Myers Squibb 597